
5-Amino-1MQ
5-amino-1MQ has been studied only in cells and mice, almost entirely by the group that developed it and its company. In obese mice given injections under the skin, it caused about 5% weight loss over 11 days and limited fat gain over about 4 weeks without changing food intake; in old mice it improved muscle repair and grip strength. It has never been given to people in a published study, so there are no human benefits, safety data or doses. Only 3.5% of an oral dose was absorbed in mice. It is not FDA-approved.
Research compound: not an approved drug or dietary supplement
This compound is sold for research and is not FDA-approved for human use or as a dietary supplement. Human evidence is limited; purity and dosing of consumer products are unverified. The data below is an evidence review for education only. Talk to a clinician before considering it.
Quick decision guide
May help most
No approved or proven use; laboratory research only
Common dosing range
No approved or established dose for people. Mouse studies injected about 10 to 34 mg per kg a day under the skin
When to expect effects
Not established in people
Watch out for
Not FDA-approved and never tested in people, so its safety is unknown; poorly absorbed by mouth in mice; in a lab screen it also blocked MAO-A, the enzyme targeted by MAO-inhibitor medicines, with unknown meaning for people; online products are unverified
What is it
5-amino-1MQ (5-amino-1-methylquinolinium) is a lab-made research compound, not an approved drug or a dietary supplement: it is not FDA-approved for any use, and on November 19, 2026 we found no published study in people on PubMed and no registered trial on ClinicalTrials.gov. It was developed by researchers at the University of Texas Medical Branch in Galveston as a blocker (inhibitor) of nicotinamide N-methyltransferase (NNMT), an enzyme that is more active in the fat tissue of obese mice. The lead researcher founded Ridgeline Therapeutics, and the later mouse studies were written partly or wholly by the company's employees, as the papers declare. Products sold under this name for weight loss or muscle have not been reviewed by FDA for identity, purity, dose or safety.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
body weight and fat in obese mice Mixed Evidence | About 5% weight loss in 11 days and less fat gain than untreated mice | None in people | Days to 4 weeks in mice |
muscle repair and strength in old mice Mixed Evidence | About 70% higher muscle torque after injury and about 40% higher grip strength than untreated old mice | None in people | 1 to 8 weeks in mice |
body weight and fat in obese mice
- Effect
- About 5% weight loss in 11 days and less fat gain than untreated mice
- Best fit
- None in people
- Time
- Days to 4 weeks in mice
muscle repair and strength in old mice
- Effect
- About 70% higher muscle torque after injury and about 40% higher grip strength than untreated old mice
- Best fit
- None in people
- Time
- 1 to 8 weeks in mice
Evidence for 2 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
body weight and fat in obese mice
Mechanism onlyIn mice made obese on a high-fat diet, injections of 5-amino-1MQ under the skin three times a day for 11 days caused a weight loss of about 5.1% from baseline, while untreated mice gained about 1.4%; fat pad mass and fat cell size fell (fat cells more than 30% smaller) and total cholesterol was about 30% lower, with no change in food intake. In a second study run by the developers' company, Ridgeline Therapeutics, about 4 weeks of once-daily injections at the higher dose (32 mg per kg) held fat gain to 1.3 g, compared with 4.7 g in untreated mice, and improved glucose tolerance, insulin levels and fatty liver changes. A third study found that combining it with a switch to a lean diet normalized body composition faster than the diet alone. These are mouse results and have never been tested in people. The lead researcher founded Ridgeline Therapeutics and other authors were its employees.
Bottom line: Injected 5-amino-1MQ reduced weight and fat in obese mice, but it has never been tested in people.
muscle repair and strength in old mice
Mechanism onlyIn 24-month-old mice with an injected muscle injury, twice-daily injections of 5-amino-1MQ (5 or 10 mg per kg) increased muscle stem cell activity, produced muscle fibers nearly twice as large in cross-section, and raised the peak torque (a measure of muscle strength) of the injured muscle by about 70% compared with untreated mice. In mice treated from 22 to 24 months of age, daily injections gave about 40% greater grip strength than untreated sedentary mice, compared with about 20% from exercise alone and about 60% when both were combined. These are mouse results from the developers' group and company, and they have not been tested in older people.
Bottom line: Old mice given injections recovered muscle better, but this has never been tested in people.
How it works
How to take it
What to track
Bottom line: No human dose exists, and nothing sold under this name has been tested in people.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
No human safety data. We found no published human study and no registered trial on November 19, 2026. The published work consists of cell and mouse studies, mostly by the developers and their company; long-term safety, effects on the liver, kidneys, heart, pregnancy and cancer risk in people are unknown.
Off-target enzyme effect. In a lab screening panel, 5-amino-1MQ at 10 micromolar blocked 67.4% of the activity of human MAO-A, the enzyme blocked by MAO-inhibitor medicines. Whether this happens in people at any dose, and whether it causes interactions with medicines or foods, has not been studied.
Poor absorption by mouth and unverified products. In mice, only 3.5% of an oral dose reached the bloodstream, and the reported effects came from injections under the skin. Products sold under this name have no FDA review of identity, purity, dose or sterility.
Who should avoid it
- Anyone outside laboratory research: the compound has never been tested in people
- People taking antidepressants or other medicines that act on serotonin or similar brain chemicals: it blocked MAO-A in a lab test, and the effect in people is unknown
Pregnancy & breastfeeding
There are no human data on 5-amino-1MQ in pregnancy, breastfeeding or fertility, and we found no pregnancy studies in animals. Avoid use if you are pregnant, breastfeeding or planning a pregnancy, and talk to your doctor.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Is 5-amino-1MQ FDA-approved?⌄
No. 5-amino-1MQ is an experimental lab compound developed as a possible drug. It is not approved by FDA for any use, and it has not completed any of the safety testing an approved medicine goes through.
Has 5-amino-1MQ been tested in people?⌄
No. On November 19, 2026 we found no published human study on PubMed and no registered trial on ClinicalTrials.gov. All published results come from cells and mice, mostly from the researchers who developed it and their company.
Does 5-amino-1MQ cause weight loss?⌄
In obese mice given injections under the skin, it caused about 5% weight loss over 11 days and limited fat gain over about 4 weeks, without changing how much they ate. No one knows whether it does anything in people, at what dose, or with what risks.
How does it compare with semaglutide or other weight-loss medicines?⌄
There is no comparison. Approved weight-loss medicines were tested in large human trials, while 5-amino-1MQ has only been tested in mice. It works on a different target (the NNMT enzyme in fat and muscle cells) and has never been studied against any approved medicine.
Do 5-amino-1MQ capsules work by mouth?⌄
That is unknown in people. In mice, only 3.5% of a dose given by mouth reached the bloodstream, and the reported weight and muscle effects came from injections under the skin.
Can I take 5-amino-1MQ with my supplements or medicines?⌄
No interaction studies exist. In a lab test it also blocked MAO-A, the enzyme targeted by MAO-inhibitor medicines, and no one has studied what that means in people. Ask a doctor or pharmacist to review your full list, especially if you take antidepressants, and tell them if you have used it.
References by claim
body weight and fat in obese mice
muscle repair and strength in old mice
Safety
ClinicalTrials.gov search for 5-amino-1MQ (no registered studies, checked November 19, 2026) · ClinicalTrials.gov link
Track 5-Amino-1MQ with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This compound is not approved by the FDA for human use and is not a dietary supplement. This page is an educational review of available research (much of it preclinical or early-stage), not a recommendation to use it. Consumer product quality is unregulated. Consult a qualified clinician.
